725 related articles for article (PubMed ID: 7844596)
21. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission: first choice for isolated extramedullary relapse?
Colleselli P; Rossetti F; Messina C; Rondelli R; Dini G; Meloni G; Miniero R; Andolina M; Locatelli F; Amici A
Bone Marrow Transplant; 1994 Nov; 14(5):821-5. PubMed ID: 7889016
[TBL] [Abstract][Full Text] [Related]
22. Indications and role of allogeneic bone marrow transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission.
Uderzo C
Haematologica; 2000 Nov; 85(11 Suppl):9-11. PubMed ID: 11268333
[TBL] [Abstract][Full Text] [Related]
23. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?
Borgmann A; Baumgarten E; Schmid H; Dopfer R; Ebell W; Göbel U; Niethammer D; Gadner H; Henze G
Bone Marrow Transplant; 1997 Dec; 20(11):939-44. PubMed ID: 9422472
[TBL] [Abstract][Full Text] [Related]
25. Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica.
Messina C; Valsecchi MG; Aricò M; Locatelli F; Rossetti F; Rondelli R; Cesaro S; Uderzo C; Conter V; Pession A; Sotti G; Loiacono G; Santoro N; Miniero R; Dini G; Favre C; Meloni G; Testi AM; Werner B; Silvestri D; Arrighini A; Varotto S; Pillon M; Basso G; Zanesco L
Bone Marrow Transplant; 1998 Jan; 21(1):9-14. PubMed ID: 9486488
[TBL] [Abstract][Full Text] [Related]
26. Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.
Kato K; Yoshida N; Matsumoto K; Matsuyama T
Pediatr Blood Cancer; 2014 Apr; 61(4):712-6. PubMed ID: 24376191
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
Satwani P; Sather H; Ozkaynak F; Heerema NA; Schultz KR; Sanders J; Kersey J; Davenport V; Trigg M; Cairo MS
Biol Blood Marrow Transplant; 2007 Feb; 13(2):218-27. PubMed ID: 17241927
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
29. Outcome of very late relapse in children with acute lymphoblastic leukemia.
Rizzari C; Valsecchi MG; Aricò M; Miniero R; Messina C; De Rossi G; Testi AM; Mura R; Galimberti S; Biondi A; Locatelli F; Conter V
Haematologica; 2004 Apr; 89(4):427-34. PubMed ID: 15075076
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission.
Bacigalupo A; Van Lint MT; Frassoni F; Occhini D; Pittaluga PA; Comelli A; Dini G; Massimo L; Marmont AM
Bone Marrow Transplant; 1986 May; 1(1):75-80. PubMed ID: 3332122
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
[TBL] [Abstract][Full Text] [Related]
33. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
Radich JP; Sanders JE; Buckner CD; Martin PJ; Petersen FB; Bensinger W; McDonald GB; Mori M; Schoch G; Hansen JA
J Clin Oncol; 1993 Feb; 11(2):304-13. PubMed ID: 8426208
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on).
Torres A; Alvarez MA; Sánchez J; Flores R; Martinez F; Gómez P; Rojas R; Herrera C; García JM; Andrés P; Velasco F; Serrano J; Román J; Rodriguez A; Martin C; Tabares S; Rodriguez JM; Parody R; Plaza E; León A; Romero R; Jean-Paul E; Prados D; Aljama R; Fernández A
Bone Marrow Transplant; 1999 Jun; 23(12):1257-60. PubMed ID: 10414912
[TBL] [Abstract][Full Text] [Related]
35. [Prognosis of children with acute myelocytic leukemia after first relapse].
Creutzig U; Ritter J; Boos J; Zimmermann M; Bender-Götze C; Stahnke K
Klin Padiatr; 1998; 210(4):207-11. PubMed ID: 9743954
[TBL] [Abstract][Full Text] [Related]
36. Outcome after first relapse in children with acute lymphoblastic leukemia: a report based on the Dutch Childhood Oncology Group (DCOG) relapse all 98 protocol.
van den Berg H; de Groot-Kruseman HA; Damen-Korbijn CM; de Bont ES; Schouten-van Meeteren AY; Hoogerbrugge PM
Pediatr Blood Cancer; 2011 Aug; 57(2):210-6. PubMed ID: 21337680
[TBL] [Abstract][Full Text] [Related]
37. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
Ritchey AK; Pollock BH; Lauer SJ; Andejeski Y; Barredo J; Buchanan GR
J Clin Oncol; 1999 Dec; 17(12):3745-52. PubMed ID: 10577846
[TBL] [Abstract][Full Text] [Related]
38. Treatment of isolated testicular relapse in childhood acute lymphoblastic leukemia: an Italian multicenter study. Associazione Italiana Ematologia ed Oncologia Pediatrica.
Uderzo C; Grazia Zurlo M; Adamoli L; Zanesco L; Aricò M; Calculli G; Comelli A; Cordero di Montezemolo L; Di Tullio MT; Guazzelli C
J Clin Oncol; 1990 Apr; 8(4):672-7. PubMed ID: 2179480
[TBL] [Abstract][Full Text] [Related]
39. Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups.
Giona F; Annino L; Testi AM; Rondelli R; Arcese W; Meloni G; Moleti ML; Mandelli F
Leuk Lymphoma; 1998 Dec; 32(1-2):89-95. PubMed ID: 10037004
[TBL] [Abstract][Full Text] [Related]
40. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]